Electronic Identification and Trust Services for Electronic... · SCHEDULE 3

2 Medicines for Human Use (Clinical Trials) Regulations 2004

Sch. 3 para. 2 · in force: yes

Captured statutory text (L5)

2 Medicines for Human Use (Clinical Trials) Regulations 2004

In regulation 2(1) (interpretation) of the Medicines for Human Use (Clinical Trials) Regulations 2004 —

(a)for the definition “electronic signature”, substitute— “electronic signature” means data in electronic form which is attached to or logically associated with other data in electronic form and which is used by the signatory to sign; ; and

(b)after the definition of “serious adverse event”, insert— “signatory” means a natural person who creates an electronic signature; .

Full captured verbatim text

In regulation 2(1) (interpretation) of the Medicines for Human Use (Clinical Trials) Regulations 2004 —

(a) for the definition “electronic signature”, substitute—

“electronic signature” means data in electronic form which is attached to or logically associated with other data in electronic form and which is used by the signatory to sign;

; and

(b) after the definition of “serious adverse event”, insert—

“signatory” means a natural person who creates an electronic signature;

.

What this provision means

Model summary, checked against the text on the left.

Relevance to Signicat: 2/3 · detailed summary (L4) Status: not needed for a short provision · Stored artifact; current recipe verification unavailable

The Medicines for Human Use Clinical Trials Regulations 2004 are amended to define electronic signature and signatory.

Only the one-line summary above is stored for this provision; the text itself is the evidence.

Refers to

No captured references.

Referred to by

schedule ref schedule_ref · reg. 5

Part summaries

0 of 0 parts have a verified summary.

L1 unavailable for current verification: the overall summary needs every part verified. Provisions and the verified summaries remain readable.

Verification findings (75)

synthesis coverage: missing/unverified L2 part-1

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-1

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-2

synthesis coverage: missing/unverified L2 part-2

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-3

synthesis coverage: missing/unverified L2 part-3

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-4

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-5

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-6

synthesis coverage: missing/unverified L2 schedule-1

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-11

synthesis coverage: missing/unverified L2 schedule-2

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-6A

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-7A

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-7B

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-27

synthesis coverage: missing/unverified L2 schedule-3

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-21

Instrument tier unavailable

Change history as published

Sch. 3 para. 7 revoked (24.2.2025) by The Procurement Act 2023 (Consequential and Other Amendments) Regulations 2025 (S.I. 2025/163), reg. 1(2), Sch. Pt. 2

Sch. 3 para. 17 revoked (24.2.2025) by The Procurement Act 2023 (Consequential and Other Amendments) Regulations 2025 (S.I. 2025/163), reg. 1(2), Sch. Pt. 2

Sch. 3 para. 20 revoked (24.2.2025) by The Procurement Act 2023 (Consequential and Other Amendments) Regulations 2025 (S.I. 2025/163), reg. 1(2), Sch. Pt. 2

Pending effects amendments not yet applied to this text

No captured pending effects.

Provenance

Every claim the system makes about this text is traceable to these identifiers.

Instrument: uk:uksi/2016/696
Part: SCHEDULE 3
Version: d49dbc556a03966e92c4becd…
Content hash: sha256 ef4856a79c6214f0254cafac…
Source: legislation.gov.uk/uksi/2016/696